Abstract
G03 Corpus callosal atrophy in Huntington's disease
Journal of neurology, neurosurgery and psychiatry, Vol.83(Suppl 1), pp.A27-A27
09/2012
DOI: 10.1136/jnnp-2012-303524.83
Abstract
BackgroundResearch into Huntington's disease (HD) has revealed white-matter loss in individuals more than 10 years prior to predicted disease onset, focused around the striatum, corpus callosum (CC) and posterior white-matter tracts. Degeneration of the CC is of interest since it provides interhemispheric connections to cortical areas known to be affected in HD.AimsThis study aims to investigate the utility of volumetric measurements of the CC in HD using a novel segmentation technique, multiple time-points and a large well-characterised cohort. Structure-function relationship in the CC will also be explored.MethodsVolumetric 3T MRI from controls, premanifest gene carriers and early HD subjects enrolled in the TRACK-HD study will be analysed at baseline and 24 months. The CC will be delineated using a semi-automated segmentation protocol. Differences in baseline volumes and atrophy rates between groups will be examined, as well as correlations between volume loss and clinical impairment.ResultsPreliminary analysis of a subset of subjects indicates that early HD subjects have reduced CC volume compared with controls and premanifest subjects (p<0.001). Increased longitudinal CC volume change was found in early HD subjects, compared with controls (p<0.001). Interestingly there was significant difference in longitudinal change between controls and premanifest subjects close to disease onset (p<0.05). This work will be extended to include multi-site data and correlations between atrophy and clinical and cognitive decline.ConclusionsMeasurement of CC atrophy may have potential as an imaging biomarker for HD and may prove useful for exploring interhemispheric structure-function relationships.FundingHelen Crawford is supported by the CHDI Foundation, a not for profit organisation dedicated to finding treatments for HD.
Details
- Title: Subtitle
- G03 Corpus callosal atrophy in Huntington's disease
- Creators
- H E Crawford - UCL Institute of Neurology, University College London, London, UKN Z Hobbs - UCL Institute of Neurology, University College London, London, UKJ Cole - UCL Institute of Neurology, University College London, London, UKE M Rees - UCL Institute of Neurology, University College London, London, UKG Owen - UCL Institute of Neurology, University College London, London, UKD R Langbehn - Department of Biostatistics (Secondary), University of Iowa, Iowa City, Iowa, USAC Frost - Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UKB Landwehrmeyer - Department of Neurology, Ulm University, Ulm, GermanyR Reilmann - Department of Neurology, University of Münster, Münster, GermanyD Craufurd - Genetic Medicine, University of Manchester, Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital, Manchester, UKJ C Stout - School of Psychology and Psychiatry, Monash University, Victoria, AustraliaA Durr - Department of Genetics and Cytogenetics, and INSERM UMR S, APHP Hôpital de la Salpêtrière, Paris, FranceB Leavitt - Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, CanadaR A Roos - Department of Neurology, Leiden University Medical Centre, Leiden, The NetherlandsS J Tabrizi - UCL Institute of Neurology, University College London, London, UKR I Scahill - UCL Institute of Neurology, University College London, London, UK
- Resource Type
- Abstract
- Publication Details
- Journal of neurology, neurosurgery and psychiatry, Vol.83(Suppl 1), pp.A27-A27
- DOI
- 10.1136/jnnp-2012-303524.83
- ISSN
- 0022-3050
- eISSN
- 1468-330X
- Language
- English
- Date published
- 09/2012
- Academic Unit
- Psychiatry; Iowa Neuroscience Institute
- Record Identifier
- 9984066388302771
Metrics
7 Record Views